The implementation of high-throughput and deep sequencing methods in routine genetic diagnostics has significantly improved the diagnostic yield in patient cohorts with growth disturbances and becomes increasingly important as the prerequisite of personalised medicine. They provide considerable chances to identify even rare and unexpected situations, nevertheless we must be aware of their limitations. A simple genetic test in the beginning of a testing cascade might also help to identify the genetic cause of specific growth disorders. However, the clinical picture of genetically caused growth disturbance phenotypes can vary widely, and there is a broad clinical overlap between different growth disturbance disorders. As a consequence, the clinical diagnosis and therewith connected the decision on the appropriate genetic test is often a challenge. In fact, the clinician asking for genetic testing has to weigh different aspects in this decision process, including appropriateness (single gene test, stepwise procedure, comprehensive testing), turn-around-time as the basis for a rapid intervention, and economic considerations. Therefore, a frequent question in that context is “what to test when”. In this review we aim to review genetic testing strategies and their strengthens and limitations, and to raise awareness for the future implementation of an interdisciplinary genome medicine in diagnoses, treatment and counselling of growth disturbances.